Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:Jan4 Jan20 Feb17 Mar17 RSS Feed twitter News Now                         

Commentary


H1N1 Blocks Speech of Venezuela's Hugo Chavez

Recombinomics Commentary 15:55
April 10, 2011

Venezuela's President Hugo Chavez suspended the transmission of program of Alo Presidente on Sunday due to the strong flu he is suffering.

"We all saw the strong flu-like symptoms that President Chavez is suffering. Tomorrow we will not broadcast Alo, Presidente ", wrote the night of Saturday the People's Minister for Communication and Information Andres Izarra, through their network user on Twitter, AVN reported.

The above translation describes the suspended broadcast of Hugo Chavez in Venezuela due to the "strong" flu, which is almost certainly the novel H1N1 circulating in Mexico and throughout Central and South America.

As noted above, it has spread to the highest levels of government in Venezuela, even though media reports describe ample levels of vaccine.  However, the vaccine is directed against California/07/2009 which is quite distinct from the novel H1N1, which has acquired A189T and S165N and vaccine failure has been cited in the United States.

Moreover, one of the fatal cases in Chihuahua, Mexico had D225N, which has been cited in multiple anecdotal reports in multiple countries, including the US.  This receptor binding domain change is linked to a more aggressive H1N1.

Release of 2011 US sequences as well as sequences from severe and fatal cases in Central and South America is long overdue.

Media link

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2011 Recombinomics.  All rights reserved.